Evidence map›Paper›PMID 33615377›Full record

ArticleG3 (Bethesda, Md.)2021

Genome of Superficieibacter maynardsmithii, a novel, antibiotic susceptible representative of Enterobacteriaceae.

Gherard Batisti Biffignandi, Marjorie J Gibbon, Marta Corbella, Harry A Thorpe, Cristina Merla, Michele Castelli, Teemu Kallonen, Katie Pegrum, Sylvain Brisse, Jukka Corander and 3 more

Open access · goldAbstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 6 institutions in 5 countries.

Gherard Batisti BiffignandiDepartment of Clinical-Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia 27100, Italy.
Marjorie J GibbonThe Milner Centre for Evolution, Department of Biology and Biochemistry, University of Bath, Bath BA 27AY, UK.
Marta CorbellaUOC Microbiologia e Virologia, Fondazione IRCCS Policlinico San Matteo, Pavia 27100, Italy.
Harry A ThorpeDepartment of Biostatistics, University of Oslo, Oslo N-0317, Norway.
Cristina MerlaUOC Microbiologia e Virologia, Fondazione IRCCS Policlinico San Matteo, Pavia 27100, Italy.
Michele CastelliDepartment of Biology and Biotechnology, University of Pavia, Pavia 27100, Italy.
Teemu KallonenDepartment of Clinical Microbiology, Turku University Hospital, Turku 20521, Finland.
Katie PegrumThe Milner Centre for Evolution, Department of Biology and Biochemistry, University of Bath, Bath BA 27AY, UK.
Sylvain BrisseInstitut Pasteur, Biodiversity and Epidemiology of Bacterial Pathogens, Paris 75015, France.
Jukka CoranderDepartment of Biostatistics, University of Oslo, Oslo N-0317, Norway.
Piero MaroneUOC Microbiologia e Virologia, Fondazione IRCCS Policlinico San Matteo, Pavia 27100, Italy.
Edward J FeilThe Milner Centre for Evolution, Department of Biology and Biochemistry, University of Bath, Bath BA 27AY, UK.
Davide SasseraDepartment of Clinical-Surgical, Diagnostic and Pediatric Sciences, University of Pavia, Pavia 27100, Italy.
Policlinico San Matteo Fondazione · ITUniversity of Bath · GBUniversity of Pavia · ITUniversity of Oslo · NOInstitut Pasteur · FRTurku University Hospital · FI

Funding

Medical Research Council MR/R00241X/1
6 · The paper itself

Abstract

During a citywide microbiological screening project in Pavia (Italy) a bacterial strain isolated from the surface of an Automated Teller Machine was classified as a Klebsiella sp. by MALDI-TOF spectrometry, and shown to be susceptible to the most antimicrobial classes by phenotypic testing. After Illumina genome sequencing and subsequent assembly, a high-quality draft genome was obtained (size = 5,051,593 bp, N50 = 615,571 bp, largest contig = 1,328,029 bp, N_contig = 17, GC content = 51.58%, coverage = 141.42), absence of antimicrobial resistance genes was confirmed, but the strain resulted to be highly divergent from all Klebsiella, and more related to other Enterobacteriaceae. The higher values of 16S rRNA identity were with members of the genera Citrobacter, Salmonella, and "Superficieibacter." An ortholog-based phylogenomic analysis indicated a sister group relationship with "Superficieibacter electus," in a distinct clade from other members of the Enterobacteriaceae family. In order to evaluate whether the novel genome represents a new species of "Superficiebacter," average nucleotide identity (ANI) and Hadamard analysis were performed on a dataset of 78 Enterobacteriaceae. The novel genome showed an ANI of 87.51% with S. electus, which compared on identity values between other members of the family, clearly indicates that the genome represents a new species within the genus "Superficieibacter." We propose for the new species the name "Superficieibacter maynardsmithii."

Indexed as

Anti-Bacterial AgentsFatty AcidsBacterial Typing TechniquesDNA, BacterialEnterobacteriaceaeItalyNucleic Acid HybridizationPhylogenyRNA, Ribosomal, 16SSequence Analysis, DNAAnti-Bacterial AgentsDNA, BacterialFatty AcidsRNA, Ribosomal, 16SANIEnterobacteriaceaeHadamardSuperficieibacter

Identifiers

PMID33615377
PMCPMC8022944
OpenAlexW3127986561

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.